EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark safeTY-engager was filed as Word mark on 11/22/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/13/2024.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018954332 |
| Application date | November 22, 2023 |
| Publication date | March 6, 2024 |
| Entry date | June 13, 2024 |
| Expiration date | November 22, 2033 |
Trademark owner
Science Campus Braunschweig-Süd
Gebäude A
Inhoffenstr. 7
38124 Braunschweig
DE
38124 Braunschweig
DE
Elzstrasse 27
79312 Emmendingen
DE
79312 Emmendingen
DE
Trademark representatives
TOWER 185 Friedrich-Ebert-Anlage 35 – 37
60327 Frankfurt am Main
DE
goods and services
1
Biochemical and biotechnological products and preparations [other than for human medical and veterinary purposes], Especially Cells and Antigen-binding molecules, micro-organisms and cells, nucleic acid based molecules, aptamer, Polypeptide based molecules, Proteins, Including t-cell receptors, anticalins, ankyrin repeat proteins, affiline and Antibodies; Monoclonal antibodies for in-vitro applications, Science or Research purposes, Especially, Mono-specific, bi-specific and multi-specific antibodies and antibody derivates, Fab (fragment antigen-binding) fragments, individual domain antibodies (nanobodies), peptide antibodies, Fc (fragment crystallisable) fusion proteins, scFv (single chain variable fragment) antibodies, dscFv (dual single chain variable fragment, diabody) antibodies and immunoconjugates and bivalent, trivalent, tetravalent and multivalent antibody forms; Antibodies for binding and/or detecting proteins, in particular surface proteins, Especially, PHLA (peptide human leukocyte antigen) specific antibodies and antibodies against a surface protein of t-cells [other than for human medical and veterinary purposes]; Agents, namely Antibodies, for use in the following fields: Diagnostic examinations for in-vivo purposes [other than for human medical and veterinary purposes]; Platform antibodies [other than for human medical and veterinary purposes] and biotechnological libraries in the following fields: Antigen-binding molecules, micro-organisms and cells, Especially Nucleic acid based or polypeptide based molecules, Especially Proteins, Especially Antibodies, Especially monoclonal antibodies, Science or For use in industry
5
Biochemical and biotechnological products and preparations, Especially Antigen-binding molecules, micro-organisms and cells, Especially Nucleic acid based molecules, Especially Aptamers or Polypeptide based molecules, Especially proteins, Including t-cell receptors, anticalins, ankyrin repeat proteins, affiline and Antibodies, Especially Monoclonal antibodies, For human medical or veterinary purposes; Pharmaceutical preparations, therapeutic drugs and agents, Especially Chemical pharmaceutical and diagnostic pharmaceutical preparations and active substances, Especially Antigen-binding molecules, Especially Cells, Nucleic acid based or polypeptide based molecules, Especially proteins, Especially Mono-specific, bi-specific and multi-specific antibodies and antibody derivatives; Especially Fab (fragment antigen binding) fragments, individual domain antibodies (nanobodies), peptide antibodies, Fc (fragment crystallisable) fusion proteins, scFv (single chain variable fragment) antibodies, dscFv (dual single chain variable fragment, diabody) antibodies and immunoconjugates and bivalent, trivalent, tetravalent and multivalent antibody forms For human medical or veterinary purposes; Antibodies for binding and/or detecting proteins, in particular surface proteins, Especially PHLA (peptide human leukocyte antigen) specific antibodies and antibodies against a surface protein of t-cells For human medical or veterinary purposes; Pharmaceutical chemical and biotechnological platform antibodies and libraries in the following fields: Antigen-binding molecules, micro-organisms and cells, Especially Nucleic acid based or polypeptide based molecules, Especially proteins, Especially Antibodies, Especially Monoclonal antibodies, For human medical or veterinary purposes
42
Scientific research and development, Pharmaceutical research and development, Biotechnological research and development and Industrial research and development, Especially Pharmaceutical research and development services and platform technologies in the following fields: Antigen-binding molecules, Proteins, Antibodies, Microorganisms and Cells; Industrial analysis and research services, Biotechnological and pharmaceutical analysis and research services, Especially Analysis, in the following fields: Molecular biology, Antigen-binding molecules, micro-organisms and cells, Especially Nucleic acid based or polypeptide based molecules, Especially Proteins, Especially Antibodies, Especially Monoclonal antibodies; Providing of technology, information and data for scientific and industrial research and development, Especially in relation to the following goods: All goods included in Classes 1 and/or 5, Especially Biochemical products, Especially Cells and Nucleic acid based or polypeptide based molecules, Especially Polypeptides, Especially Antibodies; Consultancy services in the following fields: Biotechnology and pharmaceutical research and development services, Including the providing of information, In particular in the following fields: Antigen-binding molecules, micro-organisms and cells, Especially Nucleic acid based or polypeptide based molecules, Especially Proteins, Especially Antibodies, Especially Monoclonal antibodies; Chemistry and biology laboratories, Especially Chemical and biochemical analysis and technical testing, relating to the development and manufacture of the following goods: antigen-binding molecules, micro-organisms and cells, Especially Nucleic acid based or polypeptide based molecules, Especially Proteins, Especially Antibodies, Especially Monoclonal antibodies; Product development and Quality control, Especially in the following fields: Antigen-binding molecules, micro-organisms and cells, Especially Nucleic acid based or polypeptide based molecules, Especially Proteins, Especially Antibodies, Especially Monoclonal antibodies; Clinical trials, In particular in the following fields: Antigen-binding molecules, micro-organisms and cells, Especially Nucleic acid based or polypeptide based molecules, Especially Proteins, Especially Antibodies, Especially Monoclonal antibodies
ID: 11018954332